China National Medicines Corporation Ltd.

Shanghai Stock Exchange:600511.SS

Location

Market Cap

USD 3.10 B

Share Price

USD 4.11

Avg Daily Volume

3,723,529

Change (1 day)

0.56%

Change (1 year)

-3.45%

Change (YTD)

-12.35%

China National Medicines Corporation Ltd. Operating Income Margin for the year ending December 31, 2024: 5.29%

China National Medicines Corporation Ltd. Operating Income Margin is 5.29% for the year ending December 31, 2024, a -10.69% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.
  • China National Medicines Corporation Ltd. Operating Income Margin for the year ending December 31, 2023 was 5.92%, a 0.03% change year over year.
  • China National Medicines Corporation Ltd. Operating Income Margin for the year ending December 31, 2022 was 5.92%, a 12.47% change year over year.
  • China National Medicines Corporation Ltd. Operating Income Margin for the year ending December 31, 2021 was 5.27%, a 11.15% change year over year.
  • China National Medicines Corporation Ltd. Operating Income Margin for the year ending December 31, 2020 was 4.74%, a -13.17% change year over year.
Key Data
Date Operating Income Margin Gross Profit Margin EBIT Margin EBITDA Margin